Cel Sci Corp Stock Performance
| CVM Stock | USD 4.90 0.11 2.20% |
The firm shows a Beta (market volatility) of 1.38, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CEL SCI will likely underperform. At this point, CEL SCI Corp has a negative expected return of -0.41%. Please make sure to confirm CEL SCI's maximum drawdown, as well as the relationship between the daily balance of power and period momentum indicator , to decide if CEL SCI Corp performance from the past will be repeated in the future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days CEL SCI Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Actual Historical Performance (%)
One Day Return (2.20) | Five Day Return (17.51) | Year To Date Return (4.85) | Ten Year Return (98.89) | All Time Return (99.84) |
Last Split Factor 1:30 | Dividend Date 2017-06-15 | Ex Dividend Date 1996-08-28 | Last Split Date 2025-05-20 |
1 | How Cel Sci Corporation stock expands through international markets - newser.com | 11/19/2025 |
2 | Acquisition by Geert Kersten of 8389 shares of CEL SCI at 5.96 subject to Rule 16b-3 | 12/04/2025 |
3 | CEL-SCI Reports Fiscal 2025 Results | 12/29/2025 |
4 | Acquisition by Geert Kersten of 998 shares of CEL SCI at 5.26 subject to Rule 16b-3 | 12/31/2025 |
5 | Cel-sci-sci Corp Dutton Associates Announces Investment Opinion - marketscreener.com | 01/05/2026 |
6 | Acquisition by Geert Kersten of 38023 shares of CEL SCI at 5.26 subject to Rule 16b-3 | 01/22/2026 |
7 | Acquisition by Eyal Talor of 456 shares of CEL SCI at 5.26 subject to Rule 16b-3 | 02/02/2026 |
| Begin Period Cash Flow | 4.7 B | |
| Total Cashflows From Investing Activities | -38.1 M |
CEL SCI Relative Risk vs. Return Landscape
If you would invest 704.00 in CEL SCI Corp on November 7, 2025 and sell it today you would lose (214.00) from holding CEL SCI Corp or give up 30.4% of portfolio value over 90 days. CEL SCI Corp is generating negative expected returns assuming volatility of 6.24% on return distribution over 90 days investment horizon. In other words, 56% of stocks are less volatile than CEL, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
CEL SCI Target Price Odds to finish over Current Price
The tendency of CEL Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 4.90 | 90 days | 4.90 | about 91.92 |
Based on a normal probability distribution, the odds of CEL SCI to move above the current price in 90 days from now is about 91.92 (This CEL SCI Corp probability density function shows the probability of CEL Stock to fall within a particular range of prices over 90 days) .
CEL SCI Price Density |
| Price |
Predictive Modules for CEL SCI
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CEL SCI Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of CEL SCI's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
CEL SCI Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. CEL SCI is not an exception. The market had few large corrections towards the CEL SCI's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CEL SCI Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CEL SCI within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.43 | |
β | Beta against Dow Jones | 1.38 | |
σ | Overall volatility | 0.80 | |
Ir | Information ratio | -0.07 |
CEL SCI Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CEL SCI for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CEL SCI Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| CEL SCI Corp generated a negative expected return over the last 90 days | |
| CEL SCI Corp has high historical volatility and very poor performance | |
| CEL SCI Corp has high likelihood to experience some financial distress in the next 2 years | |
| Reported Net Loss for the year was (25.41 B) with loss before taxes, overhead, and interest of (15.89 M). | |
| CEL SCI Corp has about 10.95 M in cash with (17.12 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.65. | |
| Latest headline from MacroaxisInsider: Acquisition by Eyal Talor of 456 shares of CEL SCI at 5.26 subject to Rule 16b-3 |
CEL SCI Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of CEL Stock often depends not only on the future outlook of the current and potential CEL SCI's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CEL SCI's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.1 M | |
| Cash And Short Term Investments | 11 B |
CEL SCI Fundamentals Growth
CEL Stock prices reflect investors' perceptions of the future prospects and financial health of CEL SCI, and CEL SCI fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CEL Stock performance.
| Return On Equity | -1.76 | ||||
| Return On Asset | -0.56 | ||||
| Current Valuation | 40.56 M | ||||
| Shares Outstanding | 8.41 M | ||||
| Price To Earning | (1.14) X | ||||
| Price To Book | 2.64 X | ||||
| Price To Sales | 11,797 X | ||||
| Gross Profit | (15.89 M) | ||||
| EBITDA | (20.88 M) | ||||
| Net Income | (25.41 B) | ||||
| Cash And Equivalents | 10.95 M | ||||
| Cash Per Share | 0.65 X | ||||
| Total Debt | 9.38 B | ||||
| Debt To Equity | 0.41 % | ||||
| Current Ratio | 7.71 X | ||||
| Book Value Per Share | 1.99 X | ||||
| Cash Flow From Operations | (17.12 B) | ||||
| Earnings Per Share | (6.27) X | ||||
| Market Capitalization | 41.2 M | ||||
| Total Asset | 28.16 B | ||||
| Retained Earnings | (539.42 M) | ||||
| Working Capital | 6.47 M | ||||
| Current Asset | 5.89 M | ||||
| Current Liabilities | 4.01 M | ||||
About CEL SCI Performance
By examining CEL SCI's fundamental ratios, stakeholders can obtain critical insights into CEL SCI's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that CEL SCI is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 107.86 | 102.46 | |
| Return On Equity | (1.83) | (1.92) |
Things to note about CEL SCI Corp performance evaluation
Checking the ongoing alerts about CEL SCI for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CEL SCI Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CEL SCI Corp generated a negative expected return over the last 90 days | |
| CEL SCI Corp has high historical volatility and very poor performance | |
| CEL SCI Corp has high likelihood to experience some financial distress in the next 2 years | |
| Reported Net Loss for the year was (25.41 B) with loss before taxes, overhead, and interest of (15.89 M). | |
| CEL SCI Corp has about 10.95 M in cash with (17.12 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.65. | |
| Latest headline from MacroaxisInsider: Acquisition by Eyal Talor of 456 shares of CEL SCI at 5.26 subject to Rule 16b-3 |
- Analyzing CEL SCI's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CEL SCI's stock is overvalued or undervalued compared to its peers.
- Examining CEL SCI's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CEL SCI's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CEL SCI's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CEL SCI's stock. These opinions can provide insight into CEL SCI's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CEL SCI Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Will Biotechnology sector continue expanding? Could CEL diversify its offerings? Factors like these will boost the valuation of CEL SCI. Projected growth potential of CEL fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CEL SCI data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (6.27) | Revenue Per Share | Quarterly Revenue Growth (0.63) | Return On Assets | Return On Equity |
Understanding CEL SCI Corp requires distinguishing between market price and book value, where the latter reflects CEL's accounting equity. The concept of intrinsic value - what CEL SCI's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push CEL SCI's price substantially above or below its fundamental value.
It's important to distinguish between CEL SCI's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CEL SCI should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, CEL SCI's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.